IP Library › Assignment 036903/0809
Patent Assignment
Reel/Frame 036903/0809

Assignment of Assignor's Interest

Recorded: 2015-10-28 Pages: 5
Assignor
HELSINN THERAPEUTICS (U.S.), INC.
Executed: 2015-06-06
Assignee
HELSINN HEALTHCARE SA
VIA PIAN SCAIROLO 9, LUGANO-PAZZALLO, 6912, ITALY
Covered Properties (8)
Crystal Forms of (3R)-1-(2-Methylalanyl-D-Tryptophyl)-3-(Phenylmethyl)-3-Piperidinecarboxylic Acid 1,2,2-Trimethylhydrazide
Patent: 7,825,138 →
Application: 11/165,598 →
Publication: US 2007/0004638
Crystal Forms of (3R)-1-(2-Methylalanyl-D-Tryptophyl)-3-(Phenylmethyl)-3-Piperidinecarboxylic Acid 1,2,2-Trimethylhydrazide
Patent: 8,466,173 →
Application: 12/831,009 →
Publication: US 2011/0003996
Crystal Forms of Anamorelin
Application: 13/919,518 →
Publication: US 2013/0281701
Growth Hormone Secretagogue Receptor Type 1A Agonists
Patent: 7,994,329 →
Application: 11/424,885 →
Publication: US 2007/0066540
Methods of Treating Emesis Using Growth Hormone Secretagogues
Patent: 8,288,427 →
Application: 12/082,411 →
Publication: US 2008/0300194
Methods of Treating Emesis Using Growth Hormone Secretagogues
Patent: 8,394,833 →
Application: 13/476,111 →
Publication: US 2012/0232113
Enhanced Migraine Treatments Based on Ghrelin Mimetics
Patent: 8,486,976 →
Application: 12/713,531 →
Publication: US 2010/0222388
Enhanced Migraine Treatments Based on Ghrelin Mimetics
Patent: 8,673,947 →
Application: 13/920,863 →
Publication: US 2013/0289068
Related Assignments (20)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 20, 2006
From: ANDERSEN, MAIBRITT BANSHOLM; HANSEN, BIRGIT SEHESTED; RAUN, KIRSTEN; TULLIN, SOREN
To: NOVO NORDISK A/S
Reel/Frame 018556/0043 →
Assignment of Assignor's Interest Sep 22, 2008
From: MANN, WILLIAM R.; POLVINO, WILLIAM J.
To: SAPPHIRE THERAPEUTICS
Reel/Frame 021574/0155 →
Assignment of Assignor's Interest Oct 20, 2008
From: LITTLER, BENJAMIN
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 021703/0752 →
Assignment of Assignor's Interest Oct 21, 2008
From: PAUL, BERNHARD
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 021705/0131 →
Assignment of Assignor's Interest Oct 23, 2008
From: ALBANY MOLECULAR RESEARCH, INC.
To: SAPPHIRE THERAPEUTICS
Reel/Frame 021737/0455 →
Assignment of Assignor's Interest Feb 18, 2009
From: NOVO NORDISK A/S
To: SAPPHIRE THERAPEUTICS
Reel/Frame 022277/0160 →
Assignment of Assignor's Interest Mar 23, 2009
From: LORIMER, KEITH
To: REJUVENON CORP.
Reel/Frame 022434/0215 →
Change of Name Mar 23, 2009
From: REJUVENON CORP.
To: SAPPHIRE THERAPEUTICS, INC.
Reel/Frame 022434/0297 →
Merger Mar 23, 2009
From: SAPPHIRE THERAPEUTICS, INC.
To: HELSINN THERAPEUTICS (U.S.), INC.
Reel/Frame 022432/0100 →
Assignment of Assignor's Interest Mar 23, 2009
From: PINES, SEEMON H.
To: REJUVENON CORP.
Reel/Frame 022434/0236 →
Merger Jan 14, 2010
From: SAPPHIRE THERAPEUTICS, INC.
To: HELSINN THERAPEUTICS (U.S.), INC.
Reel/Frame 023778/0301 →
Merger Jan 29, 2010
From: SAPPHIRE THERAPEUTICS, INC.
To: HELSINN THERAPEUTICS (U.S.), INC.
Reel/Frame 023869/0787 →
Assignment of Assignor's Interest Jan 29, 2010
From: ANKERSON, MICHAEL
To: HELSINN THERAPEUTICS (U.S.), INC.
Reel/Frame 023869/0734 →
Corrective Assignment to Correct the Spelling of Assignor's Name and to Correct the Name of the Assignee Previously Recorded on Reel 023869 Frame 0734. Assignor(S) Hereby Confirms the Assignor's Name Should Have Been: Michael Ankersen; and the Assignee's Name Should Have Been: Novo Nordisk A/S. Feb 1, 2010
From: ANKERSEN, MICHAEL
To: NOVO NORDISK A/S
Reel/Frame 023951/0611 →
Assignment of Assignor's Interest Apr 1, 2010
From: POLVINO, WILLIAM J.
To: HELSINN THERAPEUTICS (U.S.), INC.
Reel/Frame 024175/0144 →
Assignment of Assignor's Interest Feb 6, 2013
From: MANN, WILLIAM R.; POLINO, WILLIAM J.
To: SAPPHIRE THERAPEUTICS
Reel/Frame 029762/0803 →
Merger Feb 6, 2013
From: SAPPHIRE THERAPEUTICS, INC.
To: HELSINN THERAPEUTICS (U.S.), INC.
Reel/Frame 029766/0373 →
Corrective Assignment to Correct the Country of the Assignee's Address Previously Recorded on Reel 036903 Frame 0809. Assignor(S) Hereby Confirms the Correct Country of the Assignee's Address. Dec 14, 2015
From: HELSINN THERAPEUTICS (U.S.), INC.
To: HELSINN HEALTHCARE SA
Reel/Frame 037288/0749 →
Security Interest Dec 30, 2022
From: HELSINN HEALTHCARE SA; HELSINN THERAPEUTICS (U.S.), INC.; HELSINN BIREX PHARMACEUTICALS LIMITED
To: HAMILTON SA LLC
Reel/Frame 062254/0888 →
Release of Security Interest Sep 20, 2023
From: HAMILTON SA LLC
To: HELSINN HEALTHCARE SA; HELSINN THERAPEUTICS (U.S.), INC.; HELSINN BIREX PHARMACEUTICALS LIMITED
Reel/Frame 064961/0567 →